BlackRock Institutional Trust Company, N.A. - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260201. A total of 29 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Institutional Trust Company, N.A. ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q4 2016$22,000
-31.2%
46,5430.0%0.00%
Q3 2016$32,000
-65.6%
46,5430.0%0.00%
Q2 2016$93,000
-17.0%
46,5430.0%0.00%
Q1 2016$112,000
-68.6%
46,5430.0%0.00%
Q4 2015$357,000
+45.1%
46,5430.0%0.00%
Q3 2015$246,00046,5430.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q4 2016
NameSharesValueWeighting ↓
FNY Managed Accounts LLC 75,000$35,258,0000.24%
KINGDON CAPITAL MANAGEMENT, L.L.C. 696,455$327,0000.02%
Klingman & Associates, LLC 10,000$5,0000.00%
BLUESTEIN R H & CO LLC 76,500$36,0000.00%
OPPENHEIMER & CO INC 73,500$34,0000.00%
Renaissance Technologies 774,603$364,0000.00%
Walleye Trading LLC 6$00.00%
Bank of New York Mellon Corp 16,660$8,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11,071$5,0000.00%
SIMPLEX TRADING, LLC 200$00.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders